Floatz logo

Genotropin

Type 2 Diabetes (T2DM)

University of Aarhusprotein_peptideN/AActive
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
89/ 100

Competitive context

5 Active assets in the Type 2 Diabetes (T2DM) cohort.

Asset / SponsorPhaseRating
Obicetrapib
NewAmsterdam Pharma
Phase 3B
Ezetimibe
NewAmsterdam Pharma
Phase 3B
Dfn-15
Myopharm Limited
Phase 2CCC
VALSARTAN
Myopharm Limited
Phase 2CCC
SOMATOSTATIN
University of Aarhus
N/AD

Same molecule, other indications

Genotropin is also rated in:

isolated congenital growth hormone deficiencyDormant
BBB
Indicative ·
77 / 100
View asset →
Prader-Willi syndromeDormant
BBB
Indicative ·
77 / 100
View asset →
lipodystrophyDormant
BB
Indicative ·
71 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →